reported that PTRF expression was implicated in the protein content of tumor-derived extracellular vesicles (proteasomes) and highlighted the potential of utilizing PTRF-mediated pathways to attenuate metastatic prostate cancer [17]. The gene discussed is CAVIN1; the disease is metastatic prostate carcinoma.